U.S. FDA staff sets voting questions for Sarepta?s muscle drug
 

U.S. FDA staff sets voting questions for Sarepta?s muscle drug

April 22 (Reuters) – U.S. Food and Drug Administration staff
on Friday formulated voting questions on Sarepta Therapeutics
Inc’s muscle wasting drug, ahead of a highly
anticipated meeting of independent panel of experts on Monday to
review the drug.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...mQ:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...mQ:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/1XwQjmGFBnk